CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The GlyCANswer project aims to explore how the glycoproteome of cancer cells affects immune responses in lung and breast cancers. It seeks to identify new biomarkers and therapeutic targets to enhance immunotherapy effectiveness.
Cancer continues to be the most formidable challenge in modern medicine and the second leading cause of deaths worldwide.
However, in recent years, the treatment of unresectable cancer has undergone a paradigm shift with the advent of immunotherapy.
Yet, despite the great progress in the field, the majority of cancer patients still do not respond to any of the available immunotherapeutics and no reliable biomarker exists to predict those patients that would benefit from it.In order to facilitate…
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
